593 results on '"Meyerhans, Andreas"'
Search Results
2. Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
3. Differential kinetics of splenic CD169+ macrophage death is one underlying cause of virus infection fate regulation
4. Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells
5. Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
6. Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
7. Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
8. Author Correction: Modulating the immune response to SARS-CoV-2 by different nanocarriers delivering an mRNA expressing trimeric RBD of the spike protein: COVARNA Consortium
9. Examining the cooperativity mode of antibody and CD8+ T cell immune responses for vaccinology
10. Spatial Modelling Using Reaction–Diffusion Systems
11. Multi-scale and Integrative Modelling Approaches
12. Modelling of Human Infections
13. Basic Principles of Building a Mathematical Model of Immune Response
14. Parameter Estimation and Model Selection
15. Modelling of Experimental Infections
16. Principles of Virus–Host Interaction
17. Exploring the Therapeutic Potential of Defective Interfering Particles in Reducing the Replication of SARS-CoV-2.
18. Anti-PD-L1 Immunotherapy of Chronic Virus Infection Improves Virus Control without Augmenting Tissue Damage by Fibrosis.
19. Pan‐pox‐specific T‐cell responses in HIV‐1‐infected individuals after JYNNEOS vaccination
20. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)
21. Current Challenges
22. Mathematical Model Predicting the Kinetics of Intracellular LCMV Replication
23. Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate
24. Importance of structure-based studies for the design of a novel HIV-1 inhibitor peptide
25. Pan‐pox‐specific T‐cell responses in HIV‐1‐infected individuals after JYNNEOS vaccination.
26. Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA).
27. Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction
28. XCR1+ DCs are critical for T cell-mediated immunotherapy of chronic viral infections
29. Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents
30. Mathematical Immunology of Virus Infections
31. Peptide Assembly on the Membrane Determines the HIV-1 Inhibitory Activity of Dual-Targeting Fusion Inhibitor Peptides
32. An integrative systems biology view of host-pathogen interactions: The regulation of immunity and homeostasis is concomitant, flexible, and smart
33. Stochastic Modelling of HIV-1 Replication in a CD4 T Cell with an IFN Response
34. Soraphen A: A broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity
35. Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
36. Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells
37. Predicting the Kinetic Coordination of Immune Response Dynamics in SARS-CoV-2 Infection: Implications for Disease Pathogenesis
38. Functional cure of a chronic virus infection by shifting the virus - host equilibrium state
39. Anti-SARS-COV-2 specific immunity in HIV immunological non-responders after mRNA-based COVID-19 vaccination
40. Predicting the Cross-Coordinated Immune Response Dynamics in Sars-Cov-2 Infection: Implications for Disease Pathogenesis
41. Brief Research Report: Anti-SARS-CoV-2 Immunity in Long Lasting Responders to Cancer Immunotherapy Through mRNA-Based COVID-19 Vaccination
42. Sensitivity of SARS-CoV-2 Life Cycle to IFN Effects and ACE2 Binding Unveiled with a Stochastic Model
43. Translation and Replication of Hepatitis C Virus Genomic RNA Depends on Ancient Cellular Proteins That Control mRNA Fates
44. Early Depletion of Mycobacterium tuberculosis-Specific T Helper 1 Cell Responses after HIV-1 Infection
45. Preclinical efficacy, safety, and immunogenicity of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
46. The HIV-1 Nucleocapsid Regulates Its Own Condensation by Phase-Separated Activity-Enhancing Sequestration of the Viral Protease during Maturation
47. Intracellular Life Cycle Kinetics of SARS-CoV-2 Predicted Using Mathematical Modelling
48. Markov Chain-Based Stochastic Modelling of HIV-1 Life Cycle in a CD4 T Cell
49. Global HIV Vaccine Research Cryorepository-GHRC
50. MicroRNAs in Human Microbial Infections and Disease Outcomes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.